Except for Dr. Schroeder and Dr. Yolken, the authors are with the Sheppard Pratt Health System, Baltimore. Dr. Schroeder is with Schroeder Statistical Consulting LLC, Ellicott City, Maryland. Dr. Yolken is with the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore.
Psychiatr Serv. 2018 Feb 1;69(2):147-153. doi: 10.1176/appi.ps.201700118. Epub 2017 Sep 15.
OBJECTIVE: This study examined the prevalence of cigarette smoking and the quantity of cigarettes consumed by individuals with schizophrenia and bipolar disorder and those without a psychiatric disorder in the period 1999-2016. METHOD: A total of 1,938 individuals provided information about their cigarette smoking at enrollment into a research study for which they were selected without regard to their smoking status. Differences among groups and trends over time in smoking and cigarette consumption were examined by using multivariate models. RESULTS: Marked differences between groups were noted in the prevalence of smoking and in the quantity of cigarettes consumed. Overall, 62% of individuals with schizophrenia, 37% with bipolar disorder, and 17% of participants without a psychiatric disorder (control group) reported that they were current smokers. Smoking prevalence decreased over time in the sample primarily because of the decrease in smoking in the control group. Smokers with schizophrenia and with bipolar disorder smoked more cigarettes per day than smokers in the control group. Among smokers in all the groups, the quantity of cigarettes consumed per day declined significantly over the study period. Smoking was significantly associated with older age, less education, Caucasian race, and male gender. CONCLUSIONS: The prevalence of smoking has remained alarmingly high among individuals with schizophrenia and bipolar disorder, and the disparity with those without psychiatric disorders and with the general population is increasing. Additional measures are urgently needed to address this major public health problem.
目的:本研究调查了 1999 年至 2016 年间,精神分裂症和双相情感障碍患者以及无精神疾病个体的吸烟流行率和吸烟量。
方法:共有 1938 名个体在参加一项研究时提供了关于吸烟情况的信息,他们是在不考虑其吸烟状况的情况下被选择参加该研究的。通过使用多变量模型,研究了不同组别之间的吸烟和吸烟量差异以及随时间的变化趋势。
结果:在吸烟流行率和吸烟量方面,各组之间存在显著差异。总体而言,62%的精神分裂症患者、37%的双相情感障碍患者和 17%的无精神疾病个体(对照组)报告他们是当前吸烟者。由于对照组吸烟人数的减少,样本中的吸烟流行率随时间呈下降趋势。患有精神分裂症和双相情感障碍的吸烟者每天吸烟量多于对照组的吸烟者。在所有组别的吸烟者中,每天吸烟量在研究期间显著下降。吸烟与年龄较大、受教育程度较低、白种人以及男性有关。
结论:精神分裂症和双相情感障碍患者的吸烟流行率仍然高得惊人,与无精神疾病个体以及普通人群的差距正在扩大。迫切需要采取额外措施来解决这一重大公共卫生问题。
Psychiatr Serv. 2017-9-15
Subst Use Misuse. 2018-1-5
Psychiatry Clin Neurosci. 2004-8
BMC Public Health. 2025-4-25
Cochrane Database Syst Rev. 2024-9-4